Company Filing History:
Years Active: 2013-2022
Title: Igor Flint Tsigelny: Innovator in Personalized Medicine
Introduction
Igor Flint Tsigelny is a notable inventor based in San Diego, CA. He has made significant contributions to the field of personalized medicine, holding a total of 3 patents. His work focuses on optimizing therapeutic options and developing compounds for the treatment of synucleopathies.
Latest Patents
One of Tsigelny's latest patents is titled "Optimizing therapeutic options in personalized medicine." This invention involves a method that includes obtaining patient data, standardizing and curating it, and classifying the data to identify a combination of therapeutic options tailored to the patient's specific molecular biomarkers. The method applies a learning approach to optimize results for presentation to users.
Another significant patent is for a "Compound suitable for the treatment of synucleopathies." This invention describes a compound with a specific formula that includes various groups and components, aimed at providing therapeutic benefits for patients suffering from synucleopathies.
Career Highlights
Throughout his career, Igor Tsigelny has worked with esteemed organizations such as the University of California and Neuropore Therapies, Inc. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in medicine.
Collaborations
Tsigelny has collaborated with notable professionals in his field, including Eliezer Masliah and Wolfgang J. Wrasidlo. These collaborations have further enriched his research and development efforts.
Conclusion
Igor Flint Tsigelny is a prominent figure in the realm of personalized medicine, with a focus on optimizing therapeutic options and developing innovative compounds. His contributions continue to impact the medical field positively.